Main protease of SARS-CoV-2 serves as a bifunctional molecule in restricting type I interferon antiviral signaling

被引：0
|
作者：
Yaoxing Wu
Ling Ma
Zhen Zhuang
Sihui Cai
Zhiyao Zhao
Lingli Zhou
Jing Zhang
Pei-Hui Wang
Jincun Zhao
Jun Cui
机构：
[1] Sun Yat-sen University,MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory of Biocontrol, School of Life Sciences
[2] The First Affiliated Hospital of Guangzhou Medical University,State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Disease
[3] Shandong University,Advanced Medical Research Institute, Cheeloo College of Medicine
来源：
Signal Transduction and Targeted Therapy | / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Antiviral activities of type I interferons to SARS-CoV-2 infection
    Mantlo, Emily
    Bukreyeva, Natalya
    Maruyama, Junki
    Paessler, Slobodan
    Huang, Cheng
    ANTIVIRAL RESEARCH, 2020, 179
  • [32] Probing CAS database as prospective antiviral agents against SARS-CoV-2 main protease
    Zia, Komal
    Khan, Salman Ali
    Ashraf, Sajda
    Nur-e-Alam, Mohammad
    Ahmed, Sarfaraz
    Ul-Haq, Zaheer
    JOURNAL OF MOLECULAR STRUCTURE, 2021, 1231
  • [33] Predicting Antiviral Resistance Mutations in SARS-CoV-2 Main Protease with Computational and Experimental Screening
    Sasi, Vishnu M.
    Ullrich, Sven
    Ton, Jennifer
    Fry, Sarah E.
    Johansen-Leete, Jason
    Payne, Richard J.
    Nitsche, Christoph
    Jackson, Colin J.
    BIOCHEMISTRY, 2022, 61 (22) : 2495 - 2505
  • [34] Antiviral peptides inhibiting the main protease of SARS-CoV-2 investigated by computational screening and in vitro protease assay
    Stewart, James
    Shawon, Jakaria
    Ali, Md Ackas
    Williams, Blaise
    Shahinuzzaman, A. D. A.
    Rupa, Sharmin Akther
    Al-Adhami, Taha
    Jia, Ruoqing
    Bourque, Cole
    Faddis, Ryan
    Stone, Kaylee
    Sufian, Md Abu
    Islam, Rajib
    McShan, Andrew C.
    Rahman, Khondaker Miraz
    Halim, Mohammad A.
    JOURNAL OF PEPTIDE SCIENCE, 2024, 30 (04)
  • [35] Antiviral drug discovery by targeting the SARS-CoV-2 polyprotein processing by inhibition of the main protease
    Kandeel, Mahmoud
    Kim, Jinsoo
    Fayez, Mahmoud
    Kitade, Yukio
    Kwon, Hyung-Joo
    PEERJ, 2022, 10
  • [36] SARS-CoV-2 main protease cleaves MAGED2 to antagonize host antiviral defense
    Ju, Xiaohui
    Wang, Ziqiao
    Wang, Pengcheng
    Ren, Wenlin
    Yu, Yanying
    Yu, Yin
    Yuan, Bin
    Song, Jingwei
    Zhang, Xiaochun
    Zhang, Yu
    Xu, Chang
    Tian, Boxue
    Shi, Yi
    Zhang, Rong
    Ding, Qiang
    MBIO, 2023, 14 (04): : e0137323
  • [37] Type I Interferon Shapes Humoral Immunity to SARS-CoV-2
    Goldman-Israelow, Benjamin
    Mao, Tianyang
    Song, Eric
    Lu, Peiwen
    Wong, Patrick
    Lucas, Carolina
    Klein, Jon
    Iwasaki, Akiko
    JOURNAL OF IMMUNOLOGY, 2021, 206
  • [38] Type I and III interferon responses in SARS-CoV-2 infection
    You-Me Kim
    Eui-Cheol Shin
    Experimental & Molecular Medicine, 2021, 53 : 750 - 760
  • [39] Type I and III interferon responses in SARS-CoV-2 infection
    Kim, You-Me
    Shin, Eui-Cheol
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2021, 53 (05): : 750 - 760
  • [40] Activation and evasion of type I interferon responses by SARS-CoV-2
    Xiaobo Lei
    Xiaojing Dong
    Ruiyi Ma
    Wenjing Wang
    Xia Xiao
    Zhongqin Tian
    Conghui Wang
    Ying Wang
    Li Li
    Lili Ren
    Fei Guo
    Zhendong Zhao
    Zhuo Zhou
    Zichun Xiang
    Jianwei Wang
    Nature Communications, 11
12345